INVO Fertility
Open
$1.91
Prev. Close
$1.91
High
$1.91
Low
$1.91
Market Snapshot
$209.42K
-0.0
-734.00
$6.53M
28
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
emptyResult
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Recently from Cashu
Innovative Solutions Needed in Fertility Care: Insights for INVO Fertility
Revolutionizing Fertility Care: Bridging the Gaps for Patients A recent survey reveals critical insights into the gaps in fertility care that companies like INVO Fertility could address. Conducted by…
Survey Reveals Gaps in Fertility Care, Advocating for Holistic Solutions Beyond IVF
Reevaluating Fertility Care: A Call for Comprehensive Solutions A recent survey by Carrot, a prominent fertility and hormonal health platform, sheds light on critical shortcomings in the current ferti…
Growth in Preimplantation Genetic Testing: A Positive Outlook for INVO Fertility
Rising Demand for Preimplantation Genetic Testing Signals Growth for INVO Fertility The global preimplantation genetic testing (PGT) market is currently experiencing significant expansion, a trend tha…
Growth in Preimplantation Genetic Testing Market: Opportunities for INVO Fertility
Advancements in Preimplantation Genetic Testing Drive Market Growth The preimplantation genetic testing (PGT) market is experiencing significant growth, anticipated to reach approximately US$ 1,081.9…